Home / Companies / Aino Co., Ltd. Of North China Pharma. Group

Aino Co., Ltd. Of North China Pharma. Group FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

Latest inspection NAI · Mar 14, 2025
Last warning letter 2012

Inspections 6

0 OAI

Recalls 0 0 Class I

Warning letters 1 Latest Aug 30, 2012

510(k) clearances 0 None on file

Aino Co., Ltd. Of North China Pharma. Group has 0 FDA recalls, 6 inspections, 0 510(k) clearances and 1 compliance action on record. FDA has issued 1 warning letter to Aino Co., Ltd. Of North China Pharma. Group, the most recent on Aug 30, 2012.

What these totals cover: FDA records filed under the name "Aino Co., Ltd. Of North China Pharma. Group".

Latest inspection: Mar 14, 2025 · NAI

Summary

Record counts and when each FDA source was last refreshed
Records	Count	Last refreshed	Source as of	Status
Recalls	0	Nov 11, 2026 (checked Nov 15, 2026, unchanged)	File dated Nov 10, 2026	Current
510(k) clearances	0	Nov 15, 2026	File dated Nov 9, 2026	Current
Inspections	6	Nov 15, 2026	Newest record Nov 5, 2026	Current
Compliance actions	1	Nov 2, 2026	Newest record Oct 29, 2026	Current

FDA record by year

Aino Co., Ltd. Of North China Pharma. Group's FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Aino Co., Ltd. Of North China Pharma. Group: FDA inspections per year

Year	Inspections	OAI	Warning letters	Recall records	Class I
2026	0	0	0	0	0
2025	1	0	0	0	0
2024	0	0	0	0	0
2023	0	0	0	0	0
2022	0	0	0	0	0
2021	0	0	0	0	0
2020	0	0	0	0	0
2019	1	0	0	0	0
2018	0	0	0	0	0
2017	0	0	0	0	0

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Aino Co., Ltd. Of North China Pharma. Group as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Aino Co., Ltd. Of North China Pharma. Group yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Aino Co., Ltd. Of North China Pharma. Group FDA Warning Letters

1 warning letter on Aug 30, 2012.

Issued	Subject	Issuing office	Close-out letter
Aug 30, 2012 · Record page

A warning letter is FDA's formal notice that a company has violated FDA requirements. Each date links to the letter on fda.gov where FDA has it online. Search the text of every letter with the FDA warning letter search.

Recent FDA inspections

6 inspections from Jul 2, 2009 to Mar 14, 2025.

Date	Site	Product	Classification	FEI
Mar 14, 2025	Shijiazhuang, Hebei, China	Veterinary	No Action Indicated (NAI)	3004090057
Jan 17, 2019	Shijiazhuang, Hebei, China	Drugs	Voluntary Action Indicated (VAI)	3004090057
Apr 29, 2016	Shijiazhuang, Hebei, China	Veterinary	Voluntary Action Indicated (VAI)	3004090057
Jun 6, 2014	Shijiazhuang, Hebei, China	Veterinary	Voluntary Action Indicated (VAI)	3004090057
Nov 18, 2011	Shijiazhuang, Hebei, China	Veterinary	Voluntary Action Indicated (VAI)	3004090057
Jul 2, 2009	Shijiazhuang, Hebei, China	Veterinary	Voluntary Action Indicated (VAI)	3004090057

NAI: No objectionable conditions or practices were found during the inspection.
VAI: Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI: Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

Compliance Actions

FDA's compliance actions data lists 1 compliance action under Aino Co., Ltd. Of North China Pharma. Group: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.

Most recent: Warning Letter, Aug 30, 2012.

The warning letters in this data are listed above, together with the letters FDA posts online; a letter found in both is shown once. Other actions are not listed on this page. Search them with the FDA warning letter search or browse all compliance actions.

FDA-inspected facilities

1 inspected site, newest inspection first.

Facility	Location	Inspections	Latest
FEI 3004090057	Shijiazhuang, Hebei, China	6	Mar 14, 2025

Aino Co., Ltd. Of North China Pharma. Group and the FDA: common questions

Has Aino Co., Ltd. Of North China Pharma. Group received an FDA warning letter?

Yes. FDA has issued 1 warning letter to Aino Co., Ltd. Of North China Pharma. Group. The most recent is dated Aug 30, 2012.

Has Aino Co., Ltd. Of North China Pharma. Group received an FDA Form 483?

FDA has not published a Form 483 for "Aino Co., Ltd. Of North China Pharma. Group" in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Aino Co., Ltd. Of North China Pharma. Group?

The most recent FDA inspection on file ended Mar 14, 2025 at Shijiazhuang, Hebei, China and was classified NAI. FDA has 6 inspections of Aino Co., Ltd. Of North China Pharma. Group on file.

Need more than this page shows? Ask about Aino Co., Ltd. Of North China Pharma. Group in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.